Abstract: Maximal safe resection represents the gold standard for surgery of malignant brain tumors. As regards gross-total resection, accurate localization and precise delineation of the tumor margins are required. Intraoperative diagnostic imaging (Intra-Operative Magnetic Resonance-IOMR, Intra-Operative Computed Tomography-IOCT, Intra-Operative Ultrasound-IOUS) and dyes (fluorescence) have become relevant in brain tumor surgery, allowing for a more radical and safer tumor resection. IOUS guidance for brain tumor surgery is accurate in distinguishing tumor from normal parenchyma, and it allows a real-time intraoperative visualization. We aim to evaluate the role of IOUS in gliomas surgery and to outline specific strategies to maximize its efficacy. We performed a literature research through the Pubmed database by selecting each article which was focused on the use of IOUS in brain tumor surgery, and in particular in glioma surgery, published in the last 15 years (from 2003 to 2018). We selected 39 papers concerning the use of IOUS in brain tumor surgery, including gliomas. IOUS exerts a notable attraction due to its low cost, minimal interruption of the operational flow, and lack of radiation exposure. Our literature review shows that increasing the use of ultrasound in brain tumors allows more radical resections, thus giving rise to increases in survival.
Introduction
Maximal safe resection represents the gold standard for surgery of malignant brain tumors: gross total resection of the tumor while preserving the surrounding functional brain tissue is the main goal, since it is associated with longer survival and better patient quality of life [1] . This is particularly true for gliomas, the most common primary malignant brain tumors whose pathogenesis is still unknown [2, 3] .
Concerning gross total resection, accurate localization and precise delineation of the tumor margins are required in order to avoid devastating lesions on nervous structures [4] . Frame-based and frameless stereotactic preoperative data-based techniques, also known as neuronavigation systems, are routinely used to help surgeons plan the site of craniotomy and identify critical neural structures.
(not only the standard axial, sagittal, and coronal plane), and the ability to "understand and interpret" anatomic details displayed on the screen requires significant training and experience. Since most neurosurgeons do not receive specific US training, and US is not yet a standard diagnostic and intraoperative tool for cerebral lesions, there is an inherent difficulty in interpreting IOUS imaging and in correctly setting up the machine; these two factors both lead to a longer learning curve. Real-time intraoperative fusion of preoperative MRI/CT scans and intraoperative ultrasounds is a highly desirable solution to overcome the above-mentioned limitations.
Moreover, the greatest limitation of US is their limited ability to penetrate the skull; therefore, the most important application of IOUS in brain tumor surgery occurs after performing the craniotomy.
Since IOUS has gained great popularity in recent years, the purpose of this study is to review the current literature to evaluate the role of IOUS in gliomas surgery and to outline specific strategies to maximize its efficacy.
Literature Research and Findings
We performed a literature research through the Pubmed database by selecting each article focused on the use of IOUS in brain tumor surgery, and in particular, in glioma surgery, published in the last 15 years (from 2003 to 2018).
We performed a query using the following combinations of the Medical Subject Headings (MESH) terms: ultrasound, intraoperative ultrasound, intraoperative image guidance, glioma surgery, brain tumors surgery, high-grade glioma surgery, low-grade glioma surgery, alternating all these terms in various combinations.
We included all the studies with information on the diagnosis, the extent of the resection, and the postoperative evaluation of the degree of resection by neuroimaging.
We excluded all papers written in languages other than English and all studies with incomplete data.
After the identification of all articles that met the inclusion criteria, and after removing duplicates, we selected 39 papers dealing with the use of IOUS in brain tumor surgery, including gliomas.
Twenty-one studies were prospective and 18 were retrospectives. In particular, we focused on the usefulness of ultrasound in the surgery of cerebral gliomas.
2264 patients were included in our review: 1650 patients with a histologic diagnosis of brain glioma and 522 patients with a non-glial tumor. We did not find any information about the histological report of 94 patients [20] .
We paid special attention to the evaluation of the postoperative extent of resection (EOR), and in particular, to the achievement of gross-total resection (GTR), defined as the absence of any residual enhancement on postoperative volumetric-enhanced MRI performed within 72 h after surgical resection.
Another important point was the analysis we performed of the usefulness of IOUS used with or without other neuroimaging techniques. The results of our literature review are briefly summarized in Table 1 (see Section 3 ).
The Use of IOUS in Brain Glioma Surgery
The use of IOUS seems to have significantly increased the GTR rate achieved in brain tumors/gliomas surgery.
As regard intraoperative visualisation of the tumor and its residuals, the effectiveness of IOUS has been documented in a series of 192 HGG patients, in which the combination of neuronavigation and IOUS was also related to increased overall survival [21] . Erdogan et al. [22] , in a prospective study of 32 patients, documented a good level of agreement between intraoperative ultrasonography and postoperative contrast-enhanced MRI in detecting tumor residue; they concluded that the IOUS produces results similar to those of MRI, and therefore, can be used to maximize tumor resection.
Regarding the reliability of intraoperative ultrasound images, the best 2-D ultrasound images are obtained with a linear array probe (linear array intra-operative ultrasound, lioUS) (Philips, Amsterdam, The Netherlands), which is quite large and difficult to manoeuvre into a scalp window. For this reason, in a series of 13 LGG patients, Coburger et al. [23] compared a conventional phased array probe (conventional intra-operative ultrasound, cioUS) (Philips, Amsterdam, The Netherlands) with a new, smaller linear array probe. They observed that the lioUS images significantly corresponded to the intra-operative MRI (iMRI), and that it was unlikely that the cioUS was less accurate. The sensitivity was very high in the evaluation of the tumor residue for iMRI (83%), followed by lioUS (79%). The sensitivity for cioUS was lower (21%). On the other hand, in a series of 15 HGG patients, lioUS showed a significantly higher detection rate for residual tumors than cioUS, allowing a GTR of 73.3% [24] . Moreover, the authors found that the images produced by lioUS have few artefacts, better definition, and a more accurate visualization of the residual tumor compared with cioUS. Lothes et al. [25] in a prospective study on 11 patients with low-grade glioma (LGG) compared intraoperative MRI with conventional low-frequency intraoperative ultrasound (cioUS) and high-frequency linear array intraoperative ultrasound (lioUS). They concluded that although iMRI remains the method of choice, lioUS has been shown to be beneficial in a combined setup. Evaluation of lioUS was significantly superior to cioUS in most indications except for subcortical lesion.
Proceeding further, the implementation of 3-D US should overcome some limitations of the 2-D US by producing a volumetric image. 3-D US showed 71% sensitivity in detecting residual tumors during the resection of cerebellar lesions, in a series of 16 patients who underwent resection of intracerebral lesions. However, the sample was too small to be conclusive [26] . Unsgaard et al. [27] , in a study of 28 patients, analysed data of a 3-D IOUS-based intraoperative imaging and navigation system, comparing its usefulness in brain glioma and metastasis surgery. The results indicated that 3D US images give a good delineation of both metastases and the solid part of gliomas, thus providing a reliable guidance in tumor surgery before starting the resection. In larger series, it has been demonstrated that the use of 3-D navigable intraoperative ultrasound system may allow the surgeon to reach a 67% GTR of brain tumors [28] .
Serra et al. [29] , in a retrospective study of 22 patients, demonstrated that high frequency ultrasound (hfioUS) allows accurate detection of the tumor and detailed discrimination between normal, pathological, and oedematous tissue in all 22 cases, obtaining a GTR of 95.5%. Sweeney et al. [30] , in a retrospective review of 260 patients, have shown that the use of IOUS might help to achieve a more successful GTR (81%) in both adult and paediatric neurosurgical patients. Moreover, a combination of IOUS with other intraoperative imaging modalities (such as fluorescent tissue enhancement) provided further increases of GTR in high-grade glioma surgery.
In our department, fluorescein sodium has been used as an adjunct in glioma resection since September 2015. We recently reported a resection >95% in 83% (n = 39) of patients who underwent fluorescence-guided surgery [31] . In recent years, our preliminary experience demonstrates that the combined use of fluorescence dyeing with B-mode ultrasonography and contrast-enhanced ultrasound (CEUS) techniques helps the surgeon recognize the boundary between normal brain parenchyma and tumor. In a technical note that is not yet published, we described the removal of high-grade gliomas under fluorescence dye, B-mode ultrasonoghraphy, and CEUS technique in five patients (3 males, 2 females; mean age 55.2 years, range 36-68 years) who underwent craniotomies for intra-axial lesions, which were suspected for high-grade gliomas on preoperative MRI. According to our experience, we confirm the utility of IOUS in the initial steps of surgery and the central role of fluorescence in achieving a GTR. Ultrasound-based neuronavigation provides intraoperative support in planning the craniotomy, localizing the lesion, choosing the best point for the corticectomy (especially if deep tumors), as well as for resection control checking the boundaries structures. On the other hand, fluorescence-guided surgery appears to be a surface phenomenon; it is very useful to identify and demarcate the tumoral tissue once it is sufficiently exposed; according to our opinion, fluorescein sodium appears to be more important in the latest steps of resection. In addition, we show the effectiveness, safety, accuracy, and feasibility of ultrasound-based fluorescein-guided surgery, which is less time-and cost-consuming.
With regards to the prognosis of patients undergoing surgery for brain gliomas, it has been demonstrated that IOUS improves the prevalence of GTR and significantly increases 1-and 2-year overall survival [32] . These results may be due to the detection of residual tumors with high specificity by the use of IOUS, and hence, to the improvement of the resection rate [11] . In a series of 35 patients, Chacko et al. [33] reported that IOUS had a positive predictive value of 0.84, and Rygh et al. [34] showed similar results in a retrospective work of 19 high-grade glioma (HGG) (specificity and sensitivity of 95%). They reported a considerable decrease of specificity (up to 42%) during the resection, while the sensitivity remained as high as 87%. Nevertheless, after the resection, the sensitivity reaches a low value (26%), and the specificity has a value equal to 88%. Neuronavigation has undoubtedly provided great advantage in brain tumor surgery by improving surgical accuracy and safety. It is based on MRI or CT scans, which should be performed within 24 h prior to surgery. Unfortunately, after performing the craniotomy, changes in brain morphology may occur compared to preoperative examinations because of the brain shift [18] , which can lead to inaccuracies of between 5 and 10 mm [35] . These changes also become even more important as the tumor is debulked. As some studies highlight, intraoperative ultrasound may allow us to overcome the limit of anatomic distortion due to brain shift and tumor debulking [36] . In this regard, in a series of 67 patients, Prada et al. demonstrated that brain shift distortion may be corrected by the fusion of images between intraoperative ultrasound and preoperative magnetic resonance using neuro-navigation systems [37, 38] . They have concluded that intraoperative US imaging combined with neuro-navigator is reliable, accurate, and easy to use, allowing a continuous real-time feedback without interrupting surgery.
With regards to tumor pathological characterisation, contrast-enhanced ultrasound (CEUS) is a valuable tool for visualizing vascularization patterns that often correlates with lesion histology. Prada et al. [39] , in a series of 71 patients, found that intra-operative CEUS (iCEUS) allows for the characterization of different brain neoplasms. Furthermore, iCEUS shows afferent and efferent vessels and hyperperfused areas, thus possibly modifying the intraoperative surgical strategy. Arlt et al. [40] , in a retrospective study of 50 patients, examined the advantages of using of contrast-enhanced and three-dimensional reconstructed ultra-sound (3D CEUS) in brain tumors. The authors found that three-dimensional CEUS is a useful intraoperative imaging tool, especially for brain glioma surgery. The results of our literature review are briefly summarized in Table 1 . HGG (22) LGG (11) Others (2) 12 lioUS can be used as a safe and precise tool for intracranial image guided resection control of GBM.
It shows a significant higher detection rate of residual tumor compared to conventional cioUS.
Moiyadi et al.,
2013 [28] Clinical Article (retrospective study)
90
HGG (51) LGG (17) Others (22 To compare the ability of navigated 3D ultrasound to distinguish tumor and normal brain tissue at the tumor border zone in subsequent phases of resection.
This study shows that while ultrasound is highly accurate in delineating GBM before resection, but it appears less accurate during and after resection. During resection, there seems to be some overestimation of tumor, while small tumor remnants and infiltrated tissue in the cavity wall is underestimated after resection.
Lindner et al.,
2006 [36] Original Article (Prospective Study) 23 HGG 9 Others 14 77% / /
To prove the concept of 3D ultrasound with regard to technical effects and human impact. This includes measurement of fusion accuracy, the extent of tumor resection and the suitability for detection and capture of intraoperative brain shift as well as a protocol of operative handling as described by different neurosurgeons.
The introduction of 3D ultrasound has increased the value of neuronavigation substantially, making it possible to update several times during surgery and minimize the problem of brain shift. To expand on results from the previous study in order to provide more evidence on the usage of IOUS in the determination of gross-total resection (GTR) in both adult and pediatric patients with brain tumors.
The use of IOUS might help achieve a more successful GTR in both adult and pediatric neurosurgical patients and might improve surgical outcomes. It might be useful to study the combined efficacy of IOUS and intraoperative fluorescence imaging in achieving a higher GTR rate in invasive CNS tumor cases. To assess whether the combined use of navigated ultrasonography with the integration of FMRIB Software Library based probabilistic fiber tracking into neuronavigations technically feasible and achievable in the preoperative and intraoperative workflow.
Integration of probabilistic fiber tracking and navigated ultrasonography into intraoperative neuro-navigation facilitated anatomic orientation during glioma resection. Combination with navigated ultrasonography provided a three-dimensional estimation of intra-operative brain shift and, therefore, improved the reliability of neuronavigation.
Prada et al., 2016 [50] Prospective study 10 HGG 10 / / / To assess the capability of contrast-enhanced ultrasound (CEUS) to identify residual tumor mass during glioblastoma multiforme (GBM) surgery, to increase the extent of resection.
CEUS is extremely specific in the identification of residual tumor. The ability of CEUS to distinguish between tumor and artifacts or normal brain on B-mode is based on its capacity to show the vascularization degree. Therefore, CEUS can play a decisive role in the process of maximizing GBM resection. To assess the utility of routine use of iUS during various types of intracranial surgery.
US was highly sensitive in detecting all types of pathology, was safe and precise in planning trajectories to intraparenchymal lesions and was accurate in checking extent of resection in more than 80% of cases. iUS is a versatile and feasible tool; it could improve safety and its use may be considered in routine intracranial surgery. To examine contrast-enhanced and three-dimensional reconstructed ultrasound (3D CEUS) in brain tumor surgery regarding the up-take of contrast agent pre-and post-tumor resection, imaging quality and in comparison, with postoperative magnetic resonance imaging in different tumor entities.
Three-dimensional CEUS is a reliable intraoperative imaging modality and could improve imaging quality. Ninety percent of the high-grade gliomas (HGG, glioblastoma and astrocytoma grade III) showed high contrast uptake with an improved imaging quality in more than 50%. Gross total resection and incomplete resection of glioblastoma were adequately highlighted by 3D CEUS intraoperatively. The application of US contrast agent could be a helpful imaging tool, especially for resection control in glioblastoma surgery.
Conclusions
The main objective in brain tumor surgery is to obtain a radical resection with minimal morbidity, as radical removal has been demonstrated to be a main factor affecting overall survival.
The advent of neuronavigation has certainly brought significant advantages in brain tumor surgery, allowing identification of the lesion and its margins during the resection, but there is the great limitation of anatomic distortion after craniotomy. Intraoperative ultrasound has allowed us to overcome this limit. Furthermore, IOUS exerts a notable attraction due to the low cost, minimal interruption of the operative flow, and lack of radiation exposure. In experienced hands, sonographic features can help differentiate low-grade gliomas, which can exhibit calcifications and mild hyperechogenicity from high-grade gliomas, which can show necrotic degeneration [61] . Our literature review shows that the increasing use of ultrasound in brain tumors may allow more radical resections, thereby increasing overall survival. The studies analysed in our review show a great correlation between postoperative MRI and intraoperative ultrasound, especially for gliomas and metastases. Moreover, the lioUS appears to provide higher quality images compared to the cioUS, particularly concerning the visualization of the tumor residual. Contrast-enhanced ultrasound (CEUS) allows for the evaluation of the tumor vasculature, thus suggesting the histological diagnosis. In conclusion, the combined use of IOUS and neuronavigation may facilitate tumor removal, enhancing more radical resection, and thus improving patient overall survival and quality of life.
